C3 and neoplasm: We showed that cβigH3 could be detected in serum from patients with different types of solid cancer and that high serum levels of cβigH3 were associated with longer overall survival for patients with locally advanced or metastatic PDAC independent of relevant confounders including the tumor fibrosis marker PRO-C3.